LSW members Talus Bio and Q-Immune have been selected for the fourth cohort of Plug and Play Seattle’s accelerator program, alongside nine other startups developing technologies across industries including life sciences, space, and data centers. The cohort brings together founders working on emerging technologies, including Talus Bio and Q-Immune’s work in biotechnology and therapeutics.
LSW Members Talus Bio and Q-Immune Selected for Plug and Play Seattle Accelerator
Share: